Hello and Welcome to Patientsville.com, Your Source for all METHYLDOPA information. We are dedicated to provide You with METHYLDOPA safety information. Learn about METHYLDOPA serious adverse events reported to Food and Drug Administration (FDA).

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Health Expert

Do You Have a Question about Your Health?

We will help You understand Your condition and Feel better! Ask Our Health Experts!

Private, Confidential and Discreet

METHYLDOPA Safety Reports

Total METHYLDOPA reports: 8.
METHYLDOPA FDA safety alerts: No.
   Reported hospitalizations: 3.
Take METHYLDOPA Side Effects Survey or Share Your METHYLDOPA Story. Read More Here.

Consumer or non-health professional from CANADA reported METHYLDOPA problem on Dec 29, 2006. Female patient, 58 years of age, weighting 240.3 lb, was treated with METHYLDOPA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dehydration, hypertension, hypertensive crisis, thrombocytopenia. METHYLDOPA dosage: unknown. Patient was hospitalized. Patient recovered.

METHYLDOPA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 17, 2006. Female patient, 58 years of age, was treated with METHYLDOPA. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. METHYLDOPA dosage: 500 MG (250 MG, 2 IN 1 D), ORAL. Patient recovered.

Physician from UNITED STATES reported METHYLDOPA problem on June 27, 2007. Female patient, 28 years of age, was treated with METHYLDOPA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood pressure increased, hepatitis c positive, liver disorder. METHYLDOPA dosage: unknown. Patient recovered.

METHYLDOPA problem was reported by a Physician from UNITED STATES on Sept 01, 2006. Female patient, weighting 183.0 lb, was diagnosed with hypertension and was treated with METHYLDOPA. After drug was administered, patient experienced the following problems/side effects: hepatitis acute. METHYLDOPA dosage: 250 MG TWICE DAILY ORAL. Patient recovered.

Physician from JAPAN reported METHYLDOPA problem on Oct 02, 2006. Male patient was treated with METHYLDOPA. After drug was administered, patient experienced the following problems/side effects: caesarean section, congenital cytomegalovirus infection, cyst, deafness neurosensory, dilatation ventricular, hypokinesia neonatal, neonatal disorder. METHYLDOPA dosage: unknown. Patient was hospitalized. Patient recovered.

METHYLDOPA problem was reported by a Health Professional from UNITED STATES on Oct 23, 2006. Female patient, 42 years of age, weighting 130.0 lb, was diagnosed with hypertension and was treated with METHYLDOPA. After drug was administered, patient experienced the following problems/side effects: headache, palpitations. METHYLDOPA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported METHYLDOPA problem on Oct 18, 2006. Female patient, 58 years of age, weighting 240.3 lb, was treated with METHYLDOPA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dehydration, hypertension. METHYLDOPA dosage: unknown. Patient was hospitalized. Patient recovered.

METHYLDOPA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 25, 2007. Female patient, weighting 220.0 lb, was diagnosed with eclampsia, hypertension and was treated with METHYLDOPA. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, faeces pale, hepatic enzyme increased, ocular icterus, urine colour abnormal, yellow skin. METHYLDOPA dosage: 500 MG 2 DAILY PO. Patient recovered.

back to top

New! Check out useful Hospital Quality Data! Click on a state to continue:

ALABAMA  ALASKA  AMERICAN SAMOA  ARIZONA  ARKANSAS  CALIFORNIA  COLORADO  CONNECTICUT  DELAWARE  DISTRICT OF COLUMBIA  FEDERATED STATES OF MICRONESIA  FLORIDA  GEORGIA  GUAM  HAWAII  IDAHO  ILLINOIS  INDIANA  IOWA  KANSAS  KENTUCKY  LOUISIANA  MAINE  MARSHALL ISLANDS  MARYLAND  MASSACHUSETTS  MICHIGAN  MINNESOTA  MISSISSIPPI  MISSOURI  MONTANA  NEBRASKA  NEVADA  NEW HAMPSHIRE  NEW JERSEY  NEW MEXICO  NEW YORK  NORTH CAROLINA  NORTH DAKOTA  NORTHERN MARIANA ISLANDS  OHIO  OKLAHOMA  OREGON  PALAU  PENNSYLVANIA  PUERTO RICO  RHODE ISLAND  SOUTH CAROLINA  SOUTH DAKOTA  TENNESSEE  TEXAS  UTAH  VERMONT  VIRGIN ISLANDS  VIRGINIA  WASHINGTON  WEST VIRGINIA  WISCONSIN  WYOMING back to top

Home Care Provider Quality Reports and Home Care Provider Reviews

ALABAMA  ALASKA  AMERICAN SAMOA  ARIZONA  ARKANSAS  CALIFORNIA  COLORADO  CONNECTICUT  DELAWARE  DISTRICT OF COLUMBIA  FEDERATED STATES OF MICRONESIA  FLORIDA  GEORGIA  GUAM  HAWAII  IDAHO  ILLINOIS  INDIANA  IOWA  KANSAS  KENTUCKY  LOUISIANA  MAINE  MARSHALL ISLANDS  MARYLAND  MASSACHUSETTS  MICHIGAN  MINNESOTA  MISSISSIPPI  MISSOURI  MONTANA  NEBRASKA  NEVADA  NEW HAMPSHIRE  NEW JERSEY  NEW MEXICO  NEW YORK  NORTH CAROLINA  NORTH DAKOTA  NORTHERN MARIANA ISLANDS  OHIO  OKLAHOMA  OREGON  PALAU  PENNSYLVANIA  PUERTO RICO  RHODE ISLAND  SOUTH CAROLINA  SOUTH DAKOTA  TENNESSEE  TEXAS  UTAH  VERMONT  VIRGIN ISLANDS  VIRGINIA  WASHINGTON  WEST VIRGINIA  WISCONSIN  WYOMING

back to top

Side Effects can be harmful to Your Health! Check adverse reaction reports for these medication and vaccine side effects:

back to top

Search for additional information about METHYLDOPA here:
Thank you for visiting Patientsville.net. Hope you enjoyed finding information on METHYLDOPA and found answers to METHYLDOPA Questions